In cervical cancer cases with isolated PALN recurrence, CEA level ≤ 10 ng/mL may predict better LCR, and PET/CT appeared more reliable to exclude occult metastases and to improve LCR. This evidence concerns the gene CEACAM5 and cervical cancer.